Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LXR Biotech. -- Ignore unavailable to you. Want to Upgrade?

To: Johnny X who wrote (128)	4/24/1998 11:15:00 PM
From: Wafa SHIHABI	Read Replies (1) \| Respond to of 154

Interesting recruit, even more interesting background, more interesting yet other recent additions to board (check previous posts and releases) The Wall Street Journal -- April 24, 1998 Who's News: LXR Biotechnology Inc. LXR BIOTECHNOLOGY Inc. (Richmond, Calif.) -- G. Kirk Raab, 62 years old, was named chairman and interim chief executive of this biopharmaceutical company. Mr. Raab has been on the company's board since February and was chief executive of Genentech Inc. until 1995. He succeeds L. David Tomei, 52, LXR co-founder and a board member. Dr. Tomei, who has been chairman and CEO since 1995, becomes executive vice president and chief scientific officer and remains a director.